Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지

Survey of Life and Dietary Styles on Patients with Gastroesophageal Reflux Disease

역류성 식도질환 환자의 생활습관 및 식습관 조사연구

  • Received : 2014.03.23
  • Accepted : 2014.10.07
  • Published : 2014.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: It was surveyed how to help patients get better treatment for their disease by making complements based on the survey outcomes when the pharmacists guide how to administer medicine. Methods: A total of 142 gastroesophageal reflux disease (GERD) patients answered the self-answering questions consist of 15 items about their general characteristic, lifestyle and dietary style. The frequency of survey materials was analyzed to find out specific figures of surveyed patient's general characteristic, lifestyle and eating habits. Results: Based on the outcomes on analysis there was no difference between female and male patients. The characteristic based on the age group, as ones grow older, the number of GERD patients also increased. In case on the characteristic in lifestyle, many patients had improper habit to treat GERD. The items were smoking habits, stress control habit, sleeping postures and the way in wearing outfits. In case of postures after having a meal, they had right lifestyle. Patients had improper habit in eating food. They enjoyed pungent food and drinks which can hinder the treatment. In case of the time of having meal, eating habit of meat and vegetables and eating food less than an hour before go to bed, this research showed that they have the right lifestyle. Conclusion: This research indicate that pharmacists give guidance GERD patients to stop smoking that is causative of GERD and guide patients have mental stability, and patients avoid pungent food and drinks such as coffee, soda, chocolates and mint candies.

Keywords

References

  1. Williams DB, Welage LS. Gastroesophageal reflux In: Dipiro JT, Talbert RL, Hayes PE, et al. Pharmacotheraphy: a pathophysiologic approach, 6th ed. New York, Appleton and Lange, 2005
  2. Howard PJ, Maher L, Pryde A, et al. Symptomatic gastroesophageal reflux, abnormal esophageal acid exposure, and mucosal acid sensitivity and three separate, through related, aspects gastroesophageal reflux disease. Gut 1991;32:128-32. https://doi.org/10.1136/gut.32.2.128
  3. An evidence-based appraisal of reflux disease management: the Genval Workshop report. Gut 1999;44(Suppl):S1-S16. https://doi.org/10.1136/gut.44.2008.S1
  4. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-20. https://doi.org/10.1111/j.1572-0241.2006.00630.x
  5. Navab F, Texter EC. Gastroesophageal reflux. Pathophysiologic concepts. Arch Intern Med 1985;145:329-33. https://doi.org/10.1001/archinte.1985.00360020173027
  6. Dodds WJ, Hogan WJ, Helm JF, et al. Pathogenesis of reflux esophagitis. Gastroenterology 1981;81:376-94.
  7. Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors, Am J Dig Dis 1976;21(11):953-6. https://doi.org/10.1007/BF01071906
  8. Graham DY, Smith JL, Patterson DJ. Why do apparently healthy people use antacid tablets? Am J Gastroenterol 1983;78:257-60.
  9. Shim CS. Diagnosis and treatment of GERD for family medicine physicians. Korean J Fam Med 2001;22(5):611-8.
  10. Lee SY. Psychosocial understanding and quality of life on gastroesophageal reflux disease. Kor J Neurogastroenterol Motil 2001;7:367-74.
  11. Fennerty MB, Castell D, Fendrick AM, et al. The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment: suggested disease management guidelines. Arch Intern Med 1996;156(5):477-84. https://doi.org/10.1001/archinte.1996.00440050019003
  12. DeVault KR, Castell DO. Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Arch Intern Med 1995;155:2165-73. https://doi.org/10.1001/archinte.1995.00430200044008
  13. Hamby CA, Kale-Pradhan PB. Gastroesophageal reflux disease: a treatment approach. Hosp Pharm 1997;32(10):1347-56.
  14. Konturek SJ, Brzozowshi T, Drozdowicw D, et al. Healing of chronic gastroduodenal ulcerations by antiacids: role of prostaglandins and epidermal growth factor. Dig Dis Sci 1990;35(9):1121-9. https://doi.org/10.1007/BF01537585
  15. Hollander D, Tranawski A. Are antacids cytoprotective? Gut 1989;20:145-7.
  16. Stanciu C, Bennett JR. Alginate and antiacid in the reduction of gastroesophageal reflux. Lancet 1974;1:109-11.
  17. Chevrel B. A comparative crossover study on the treatment of heartburn and epigastric pain: liquid Gaviscon and a magnesium-aluminum antiacid gel. J Int Med Res 1980;8: 300-2. https://doi.org/10.1177/030006058000800411
  18. Graham DY, Lanza F, Dorsch ER. Symptomatic reflux esophagitis: a double-blind controlled comparison of antiacids and alginate. Curr Ther Res 1977;22:653-8.
  19. Schentag JJ, Goss TF. Pharmacokinetics and pharmacodynamics of acid suppressive agent in patients with gastroesophageal reflux disease. Am J Hosp Pharm 1993; 50(suppl 1):s7-s10.
  20. Hetzel DJ, Dent J, Reed WD, et al. Healing and replace of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988;95:903-12. https://doi.org/10.1016/0016-5085(88)90162-X
  21. Garnett WR. Efficacy, safety, and cost issues in managing patients with gastroesophageal reflux disease. Am J Hosp Pharm 1993;50(supple 1):s11-s18.
  22. Hatlebakk JG, Berstad A, Carling L, et al. Lansoprazole versus omeprazole in short-term treatment of reflux esophagitis. Results of a Scandinavian multicenter trial. Scand J Gastroenterol 1993;28:224-8. https://doi.org/10.3109/00365529309096076
  23. Robinson M. Prokinetic therapy for gastroesophageal reflux disease. Am Fam Physician. 1995;52(3):957-62, 965-6.
  24. Van Pinxteren B, Sigterman KE, Bonis P, et al. Short-term treatment with proton pump inhibitors, $H_2$-receptor antagonists and prokinetics for gastroesophageal reflux disease-like symptoms and endoscopy negative reflux disease. http://www2.cochrane.org/reviews/en/ab002095.html
  25. Farrekk RL, Roling GT, Castell DO. Cholinergic therapy of chronic heartburn. Ann Intern Med 1974;8:573-6.
  26. Saco LS, Orlando RC, Levinson SL, et al. Double-blind controlled trial of bethanechol and antacid versus placebo and antacid in the treatment of erosive esophagitis. Gastroenterology 1982;82:1369-73.
  27. Fink SM, Lange RC, McCallum RW. Effect of metoclopramide on normal and delayed gastric emptying in gastroesophageal reflux patients. Dig Dis Sci 1983;28:1057-61. https://doi.org/10.1007/BF01295802
  28. Dennish GW, Castell DO. Inhibitory effect of smoking on the lower esophageal sphincter. N Eng J Med 1971;284: 1136-7. https://doi.org/10.1056/NEJM197105202842007
  29. Stanciu C, Bennett JR. Smoking and gastroesophageal reflux. BMJ 1972;3:793-5. https://doi.org/10.1136/bmj.3.5830.793
  30. Kahrilas PJ, Gupt a RR. Mechanisms of acid reflux associated with cigarette smoking. Gut 1990;31:4-10. https://doi.org/10.1136/gut.31.1.4
  31. Kjellen G, Tibbling L. Influence of body position, dry and water swallows, smoking, and alcohol on esophageal acid clearing. Scand J Gastroenterol 1978;13:283-8. https://doi.org/10.3109/00365527809179821
  32. Kahrilas PJ, Gupta RR. The effect of cigarette smoking on salivation and esophageal acid clearance. J Lab Clin Med 1989;114(4):431-8.
  33. Stress Complicates Gastroesophageal Reflux Disease Treatment. http://www.associatedcontent.com/article/417781/stress_complicates_gastroesophageal.html
  34. Stanciu C, Bennett JR. Effects of posture on gastroesophageal ref lux, Digestion 1977;15:104-9. https://doi.org/10.1159/000197991
  35. Johnson LF, DeMeester TR. Evaluation of elevation of the head of the bed, bethanechol, and antacid foam tablets on gastroesophageal ref lux, Dig Dis Sci 1981;26:673-80. https://doi.org/10.1007/BF01316854
  36. Johnson LF, DeMeester TR. Twenty four hour pH monitoring of the distal esophagus. Am J Gastroenterol 1974;62:325-32.
  37. Babka JC, Hager GW, Castell DO. The effect of body position on lower esophagus sphincter pressure. Dig Dis 1973;18:441-2. https://doi.org/10.1007/BF01071996
  38. DeMeester TR, Johnson LF, Joseph GJ. Patterns of gastroesophageal reflux in health and disease. Annsurg 1976;184:459-70.
  39. Kjellen G, Tibbling L. Influence of body position, dry and water swallows, smoking, and alcohol on esophageal acid clearing. Scand J Gastroenterol 1978;13:283-8. https://doi.org/10.3109/00365527809179821
  40. Dent J. Recent views on the pathogenesis of gastroesophageal reflux disease. Baillieres Clin gastroenterol 1987;1:727-45. https://doi.org/10.1016/0950-3528(87)90016-9
  41. Holloway RH, Hongo M, Berger K. Gastric distension: a mechanism for postprandial gastroesophageal reflux. Gastroenterology 1985;89:779-81. https://doi.org/10.1016/0016-5085(85)90572-4
  42. McArthur K, Hogan D, Isenberg JI. Relative stimulatory effects of commonly ingested beverages on gastric acid secretion in humans. Gast roenterology 1982;83:199-203.
  43. Murphy DW, Castell DO. Chocolate and heartburn: evidence of increased esophageal acid exposure after chocolate ingestion. Am J Gastroenterol 1988;83:633-6.
  44. Sigmund CJ, McNally EF. The action of a carminative on the lower esophageal sphincter. Gastroenterology 1969; 56:13-8.
  45. Nebel OT, Castell DO. Lower esophageal sphincter pressure changes after food digestion. Gastroenterology 1972;63:778-83.
  46. Becker DJ, Sinclair J, Castell DO, et al. A comparison of high and low fat meals on postprandial esophageal acid exposure, Am J Gastroenterol 1989;84:782-6.
  47. Um YR, Lee SM, Kim EM, et al.: In Clinical Nutrition Management, 2nd ed. Korean Society of Nutritionist, Seoul, p.82, 1995.